LONDON, ONTARIO, Sep 21, 2015 (Marketwired via COMTEX) —
Sernova Corp. (SVA)(frankfurt:PSH)(otcqb:SEOVF), a
leading clinical stage, regenerative medicine company developing
biologically compatible, implantable medical device and therapeutic
cellular technologies is pleased to announce it has been listed for
trading on the OTCQB market exchange in the United States under the
symbol “SEOVF”.
“Admission to the OTCQB expands Sernova’s presence in the United
States, will provide our existing U.S. shareholders with an improved
trading platform, and is part of our long-term strategy to introduce
the company to a broader range of institutional and retail
investors,” stated Dr. Philip Toleikis, President and CEO of Sernova.
“This is a timely move given the Company’s growing international
presence with its expanding corporate and academic collaborations,
product development programs and partnering discussions.”
The Company will be embarking on a comprehensive investor relations
effort attending institutional conferences and targeted investor
meetings in Toronto, Atlanta, Boston and New York.
About Sernova
Sernova Corp is a clinical stage regenerative medicine company
developing medical technologies for the treatment of chronic
debilitating metabolic diseases such as diabetes, blood disorders
including hemophilia and other diseases treated through replacement
of proteins or hormones missing or in short supply within the body.
Sernova is developing the Cell Pouch(TM), an implantable medical
device for therapeutic cells (donor, xenogeneic or stem cell derived
therapeutic cells) which then release proteins and/or hormones as
required.
Forward Looking Information
This release may contain forward-looking statements. Forward-looking
statements are statements that are not historical facts and are
generally, but not always, identified by the words “expects”,
“plans”, “anticipates”, “believes”, “intends”, “estimates”,
“projects”, “potential” and similar expressions, or that events or
conditions “will”, “would”, “may”, “could” or “should” occur.
Although Sernova believes the expectations expressed in such
forward-looking statements are based on reasonable assumptions, such
statements are not guarantees of future performance and actual
results may differ materially from those in forward looking
statements. Forward-looking statements, which include our beliefs
about the functionality of the Cell Pouch and our expectations of the
potential benefits of listing on the OTCQB, are based on the beliefs,
estimates and opinions of Sernova’s management on the date such
statements were made. Sernova expressly disclaims any intention or
obligation to update or revise any forward-looking statements whether
as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Contacts: Sernova Corp. Philip Toleikis, Ph.D. President and CEO (604) 961-2939 philip.toleikis@sernova.com / info@sernova.com www.sernova.com Ray Matthews Associates Suite 601-128 West Cordova Street, Vancouver, BC V6B 0E6 (604) 818-7778 www.raymatthews.ca
SOURCE: Sernova Corp.
(C) 2015 Marketwire L.P. All rights reserved.